Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Orthofix Medical (OFIX) Short-Term Debt issuances (2010 - 2013)

Orthofix Medical (OFIX) reported Short-Term Debt issuances of -$1000.0 for Q2 2013, up 99.89% year-on-year from -$500.28 in Q2 2012, and up 93.33% quarter-over-quarter from -$15000.0 in Q1 2013.

Orthofix Medical (OFIX) has 4 years of Short-Term Debt issuances data on file, last reported at -$1000.0 in Q2 2013.

  • For the quarter ending Q2 2013, Short-Term Debt issuances rose 99.89% year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2020 stood at -$1000.0 (changed N/A YoY), and the FY2020 full-year result was $100.0 million, changed N/A from the prior year.
  • Short-Term Debt issuances for Q2 2013 stood at -$1000.0, up from -$15000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $1.2 million in Q4 2010 and bottomed at -$1.9 million in Q1 2011.
  • A 4-year average of -$264500.0 and a median of -$110000.0 in 2012 frame the typical range for Short-Term Debt issuances.
  • Peak annual rise in Short-Term Debt issuances reached 103.66% in 2012, while the deepest fall reached 486.27% in 2012.
  • Tracing OFIX's Short-Term Debt issuances over 4 years: stood at $1.2 million in 2010, then plunged by 93.01% to $81000.0 in 2011, then slumped by 422.22% to -$261000.0 in 2012, then soared by 99.62% to -$1000.0 in 2013.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods registered -$1000.0, -$15000.0, and -$261000.0 for Q2 2013, Q1 2013, and Q4 2012 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 31.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -1.23 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 37.80 Mn
10 Orthofix Medical 375.38 Mn 254.51 Mn 139.55 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2013 -1,000.00
Jun 30, 2013 -1,000.00
Mar 31, 2013 -15,000.00
Mar 31, 2013 -15,000.00
Dec 31, 2012 -261,000.00
Dec 31, 2012 -261,000.00
Sep 30, 2012 -205,000.00
Sep 30, 2012 -205,000.00
Jun 30, 2012 -900,000.00
Jun 30, 2012 -900,000.00
Mar 31, 2012 69,000.00
Mar 31, 2012 69,000.00
Dec 31, 2011 81,000.00
Dec 31, 2011 81,000.00
Sep 30, 2011 -989,000.00
Sep 30, 2011 -989,000.00
Jun 30, 2011 233,000.00
Jun 30, 2011 233,000.00
Mar 31, 2011 -1.89 Mn
Mar 31, 2011 -1.89 Mn
Dec 31, 2010 1.16 Mn
Dec 31, 2010 1.16 Mn
Sep 30, 2010 -459,000.00
Sep 30, 2010 -459,000.00